Vident Investment Advisory, LLC Sangamo Therapeutics, Inc Transaction History

Vident Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $2,063 - $4,561	1,243 Added 3.86%	33,486 $58,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $20,946 - $38,339	7,562 Added 30.64%	32,243 $101,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $10,551 - $15,789	2,471 Added 11.13%	24,681 $121,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $14,418 - $27,299	4,396 Added 24.68%	22,210 $92,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $19,037 - $28,464	-3,640 Reduced 16.97%	17,814 $103,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $156,399 - $235,350	21,454 New	21,454 $161,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $163,729 - $218,245	-18,172 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.17 - $12.64 $184,809 - $229,694	18,172 New	18,172 $218,000

111

56.7M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.